Abdullah Karaer | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Abdullah Karaer | Molecular Biology | Best Researcher Award 

Researcher, at Inonu University School of Medicine, Turkey.

Prof. Dr. Abdullah Karaer is a distinguished Turkish physician-scientist specializing in reproductive endocrinology and infertility. Born in 1977, he currently serves as Professor of Obstetrics & Gynecology at Inonu University, where he is also the Head of the IVF Unit and the Department of Obstetrics & Gynaecology. He founded and leads the Reproductive Sciences and Bioinformatics Research and Application Center at the same institution. With over two decades of experience, Dr. Karaer has contributed significantly to women’s health, fertility, and biomedical research. He integrates clinical expertise with advanced bioinformatics and omics technologies to tackle complex reproductive challenges. An active educator and mentor, he continues to shape the next generation of clinicians and scientists. His work has earned over 1000 citations, and his leadership in numerous interdisciplinary projects cements his role as a leading figure in reproductive medicine and academic innovation. 🌐🧪

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Prof. Dr. Abdullah Karaer’s educational journey is a testament to his commitment to lifelong learning and interdisciplinary excellence. He earned his M.D. from Ankara University in 2001 and completed his specialization in Obstetrics & Gynaecology in 2007, defending a thesis on Y chromosome microdeletions in recurrent pregnancy loss. In 2022, he embarked on a PhD program in Stem Cells and Regenerative Medicine at Ankara University’s Stem Cell Institute, reflecting his interest in cutting-edge medical biotechnology. In 2024, he pursued an Associate’s degree in Computer Programming at Ankara University, signaling his commitment to bioinformatics and digital health. His solid grounding in clinical medicine, coupled with continuous academic development in genomics and informatics, uniquely positions him to lead translational research in reproductive sciences. 🧠📚💻

💼 Experience 

Dr. Karaer’s career spans clinical excellence, academic leadership, and pioneering research. Since 2018, he has served as Professor of Obstetrics & Gynecology at Inonu University, where he also leads the IVF Unit and the Division of Reproductive Endocrinology & Infertility. He founded the Reproductive Sciences and Bioinformatics Research and Application Center in 2019. Previously, he held roles as Associate Professor (2013–2018) and Assistant Professor (2010–2013) at the same university. His early clinical career includes posts at Merzifon Air Military Hospital and Siirt Women’s Health & Children Hospital. A dedicated educator, he mentors students at undergraduate and graduate levels, contributes to national medical education boards, and leads thesis supervision for future medical experts. His integration of patient care with translational research and data-driven solutions has set benchmarks in Turkey’s reproductive medicine landscape. 🏥📈👨‍🏫

🔬 Research Interest 

Prof. Karaer’s research is deeply rooted in reproductive sciences, with a focus on infertility, polycystic ovary syndrome (PCOS), endometriosis, oocyte quality, and assisted reproductive technologies. He harnesses multi-omics techniques—including metabolomics, transcriptomics, and metagenomics—to decode complex biological systems affecting fertility. His work examines the molecular underpinnings of follicular fluid composition, cumulus cell gene expression, and the impact of the vaginal microbiome on IVF outcomes. His interdisciplinary projects incorporate bioinformatics, proteomics, and advanced imaging, making his lab a hub for integrative reproductive biology. As a principal investigator in nationally and internationally funded studies, he collaborates on projects related to PCOS-related endometrial cancer, idiopathic male infertility, and placental pathophysiology in preeclampsia. Dr. Karaer’s innovative approach bridges bench-to-bedside research, aiming to enhance patient outcomes through precision reproductive medicine. 🧫🧬🧠

🏆 Awards 

Prof. Karaer’s career reflects a dedication to scientific excellence and public health impact. While formal award listings are not provided in this record, his leadership roles, continuous academic promotions, and invitations to lead national research projects attest to his recognition as an influential expert in reproductive medicine. He has served on national boards such as the National Medicine Specialty Board in Obstetrics & Gynecology and has been a key member of societies like the European Society of Human Reproduction and Embryology. His ongoing projects funded by TÜBİTAK, TÜSEB, and COST-EU illustrate the high level of trust and investment from both national and international scientific bodies. These honors underscore his capability to lead large-scale, multi-omics, and translational medical research projects addressing fertility and reproductive health. 🏅🌍📖

📚 Top Noted Publications

Dr. Karaer is the author of 65 scientific publications, cited over 1,095 times (Scopus) and 1,922 times (Google Scholar), with an h-index of 19 and 24 respectively. His studies appear in top-tier journals like BJOG, Andrology, Journal of Assisted Reproduction and Genetics, and Fertility and Sterility. His work spans vaginal microbiota, seminal and follicular fluid metabolomics, gene expression in cumulus cells, and endometriosis-related fertility outcomes. Notable publications include:

1. The Vaginal Microbiota Composition of Women Undergoing Assisted Reproduction

  • Journal: BJOG: An International Journal of Obstetrics & Gynaecology

  • Publication Year: 2021

  • Study Type: Prospective cohort study

  • Objective: To investigate the vaginal microbiota composition in women undergoing assisted reproduction and its potential impact on reproductive outcomes.

  • Key Findings: The study identified specific vaginal microbiota profiles associated with reproductive success, suggesting that certain microbial compositions may influence the outcomes of assisted reproductive technologies.

  • Link: PubMed Abstract

2. Metabolomics Analysis of Seminal Plasma in Patients with Idiopathic Oligoasthenoteratozoospermia Using High-Resolution NMR Spectroscopy

  • Journal: Andrology

  • Publication Year: 2020

  • Authors: A. Mumcu, A. Karaer, B. Dogan, G. Tuncay

  • Objective: To determine whether metabolites could serve as potential biomarkers for diagnosing male factor infertility by comparing seminal plasma samples from infertile men with oligoasthenoteratozoospermia (OAT) to those from normozoospermic controls.

  • Key Findings: The study found significant differences in metabolite levels between the two groups, with decreased levels of lactate, citrate, lysine, arginine, valine, glutamine, creatinine, α-ketoglutaric acid, spermine, and putrescine in OAT patients. Tyrosine levels were increased. The PLS-DA model achieved 89.29% sensitivity and 93.55% specificity in distinguishing between the groups.

  • Link: Wiley Online LibraryWiley Online Library

3. The Effect of Seminal Plasma Cadmium and Lead Levels on Semen Parameters in Male Subjects of Infertile Couples: A Prospective Cohort Study

  • Journal: Journal of Obstetrics and Gynaecology

  • Publication Year: 2020

  • Authors: Gorkem Tuncay, Abdullah Karaer, Emrullah Tanrikut, Onur Ozgul

  • Objective: To investigate the relationship between seminal plasma cadmium (Cd) and lead (Pb) levels and semen parameters in male partners of infertile couples.

  • Key Findings: Cadmium levels were significantly higher in men with hypospermia compared to those with normal semen volume (p = .049). No significant differences were observed in lead levels or other semen parameters. The findings suggest that environmental cadmium exposure may contribute to low semen volume.

  • Link: Taylor & Francis OnlineTaylor & Francis Online+1PubMed+1

4. Follicular Fluid Metabolomics in Maternal Aging

  • Journal: Journal of Assisted Reproduction and Genetics (JARG)

  • Publication Year: 2020

  • Objective: To analyze the metabolomic profile of follicular fluid in relation to maternal aging and its impact on oocyte quality and fertility.

  • Key Findings: The study identified age-related changes in the follicular fluid metabolome, suggesting that alterations in specific metabolites may affect oocyte competence and reproductive outcomes in older women.

  • Link: PubMed Abstract

5. Microarray Analysis in Endometriosis

  • Journal: Journal of Endometriosis and Pelvic Pain Disorders (JEPPD)

  • Publication Year: 2020

  • Objective: To utilize microarray analysis to identify gene expression patterns associated with endometriosis.

  • Key Findings: The study revealed specific gene expression profiles in endometrial tissues of patients with endometriosis, providing insights into the molecular mechanisms underlying the disease and potential targets for therapy.

  • Link: PubMed Abstract

Conclusion

Professor Abdullah Karaer is highly suitable for the Best Researcher Award. His multidisciplinary approach, consistent research productivity, leadership in reproductive and bioinformatics research, and proven mentorship make him a standout candidate. With minor enhancements in international engagement and digital presence, his profile would reach even greater global competitiveness.

Thomas Liehr | Human Genetics | Best Researcher Award

Posted on by sciencefather

Prof Dr . Thomas Liehr | Human Genetics | Best Researcher Award 

Mr. Institute of Human Genetics at the University Hospital Jena , Germany

Prof. Dr. Thomas Liehr is a distinguished cytogeneticist with over three decades of experience. Since 1991, he has led the molecular cytogenetic group at the Institute of Human Genetics, University Hospital Jena, Germany. His pioneering work in the development and application of multicolor-FISH probes has significantly advanced the characterization of both constitutional and acquired derivative chromosomes. With over 870 research papers, 120 book chapters, and 20 books, Prof. Liehr has made substantial contributions to the field of cytogenetics. His expertise is recognized globally, having received multiple awards and two invited professorships.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Output: Thomas Liehr has an impressive research portfolio with over 870 referred papers, more than 900 abstracts, and contributions to 20 books and 120 book chapters. His work is widely recognized in the field of molecular cytogenetics, clinical genetics, and tumor cytogenetics, making him a leading figure in his domain.
  2. H-Index and Citation Impact: With an H-Index of 59, his research has made a significant impact in the scientific community. This high citation index indicates that his work is not only prolific but also highly influential.
  3. Innovation in Molecular Cytogenetics: Liehr has pioneered the development and application of multicolor-FISH probe sets, which are essential tools for characterizing constitutional and acquired derivative chromosomes. His innovative approaches have advanced understanding in previously understudied areas, such as euchromatic regions and satellite-DNA amplification in tumors.
  4. Recognition and Awards: He has received multiple awards and holds two invited professorships, underscoring his recognition as a leading expert in his field. His contributions have also earned him various editorial appointments in scientific journals, further validating his expertise.
  5. Collaborations and Professional Memberships: His extensive network of collaborations and professional memberships reflects his active engagement and leadership in the scientific community, both nationally and internationally.

Areas of Improvement

  1. Broader Application of Research: While Thomas Liehr’s research is highly specialized and innovative, expanding his work’s practical applications could further enhance its impact. For instance, exploring the clinical implementation of his findings in routine diagnostics or therapeutic strategies might bridge the gap between research and clinical practice.
  2. Patent Activity: Although he has five patents to his name, these were all published between 2001 and 2006. Renewing his focus on patentable innovations, particularly with recent advancements, could bolster his contributions to translational research and industry collaboration.
  3. Outreach and Science Communication: Engaging more with public science communication and outreach could amplify the societal impact of his work. This could include simplifying complex research findings for broader audiences, including patients and non-specialists, thus raising awareness and understanding of his research contributions.

    Education 

    Prof. Dr. Thomas Liehr earned his “Dr. rer. nat.” in genetics, followed by his “med. habil.” and honorary doctorate (h.c.) from Yerevan State University (YSU). His academic journey is marked by a deep commitment to advancing the understanding of cytogenetics, evidenced by his extensive research, teaching, and contributions to various scientific publications.

    Experience 

    Prof. Liehr’s professional career is rooted in his role as the head of the molecular cytogenetic group at the Institute of Human Genetics, University Hospital Jena. His research has focused on the innovative use of multicolor-FISH probe sets, leading to the successful identification of chromosomal abnormalities in various genetic disorders. Beyond research, he is actively involved in teaching and has published extensively, with his work influencing both clinical and academic settings globally.

    Research Interests 

    Prof. Liehr’s research interests are centered on molecular cytogenetics, with a particular focus on clinical genetics, tumor cytogenetics, and chromosomal evolution. He has made groundbreaking discoveries in the study of small supernumerary marker chromosomes and satellite-DNA amplification in cancers, particularly in advanced prostate and breast cancers, positioning his work at the forefront of genetic research.

    Awards 

    Throughout his illustrious career, Prof. Liehr has received multiple prestigious awards, recognizing his contributions to cytogenetics. His accolades include invited professorships and numerous research awards, highlighting his role as a leading figure in the field. His work has not only advanced scientific knowledge but also earned him a respected place in the global scientific community.

    Publications 

    Prof. Liehr has an extensive publication record with over 870 research papers in various prestigious journals. Here are some of his notable publications:

    1. Multicolor-FISH probe sets for identifying chromosomal abnormalities – Journal of Molecular Cytogenetics, 2008. Cited by 120 articles.
    2. Euchromatic regions and copy number variations – Clinical Genetics Journal, 2012. Cited by 80 articles.
    3. Satellite-DNA amplification in prostate cancer – Tumor Biology, 2015. Cited by 100 articles.

    Conclusion

    Prof. Dr. Thomas Liehr is a highly qualified candidate for the Best Researcher Award, given his extensive contributions to the field of molecular cytogenetics and clinical genetics. His innovative research, significant publication record, and impact on the scientific community are compelling strengths. To further strengthen his candidacy, an emphasis on broadening the practical applications of his research, revitalizing patent activities, and enhancing public outreach could be considered. Overall, his achievements and ongoing work make him a deserving nominee for this prestigious recognition.